arrow
G

Gerben J.C. Zwezerijnen

Cancer Center Amsterdam
H指数:26
被引数:2,058

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Differentiation of axial spondyloarthritis-related lesions from degenerative lesions on Na[18F]Fluoride PET/CT in a longitudinal dataset of patients with radiographic axial spondyloarthritis

利用Na[18F]Fluoride PET/CT纵向数据集鉴别影像学轴性脊柱关节炎患者的轴性脊柱关节炎相关病变与退行性病变

2026-10-090
OAAI
In-human assessment of target engagement and blockade of radiolabeled BI 765063, an anti-SIRPα antibody

在人中评估放射性标记的BI 765063(一种抗-SIRPα抗体)的靶点结合和阻断作用

2026-08-130
OAAI
A Lesion-adaptive Segmentation Approach for Tumor Delineation on FDG PET/CT in Diffuse Large B-cell Lymphoma Patients

一种适用于弥漫性大B细胞淋巴瘤患者FDG PET/CT肿瘤勾画的病灶自适应分割方法

2026-02-140
OAAI
Predicting 2-year time to progression in diffuse large B cell lymphoma using 3D CNNs on whole-body PET/CT scans

使用3D CNNs在全身PET/CT扫描上预测弥漫性大B细胞淋巴瘤的2年进展时间

2025-11-280
OAAI
Risk prediction in diffuse large B-cell lymphoma improves when combining baseline PET features with interim PET response

弥漫性大B细胞淋巴瘤的风险预测在结合基线PET特征与中期PET反应时得到改善。

2025-10-010
OAAI
89Zr-mAb uptake interpretation requires the use of tissue to plasma ratios corrected for antibody catabolism

89Zr-mAb的摄取解释需要使用校正了抗体分解代谢的组织与血浆比率。

2025-09-260
OA
Large B-cell lymphoma (LBCL): EHA Clinical Practice Guidelines for diagnosis, treatment, and follow-up

弥漫大B细胞淋巴瘤(LBCL):EHA 诊断、治疗和随访临床实践指南

2025-09-230
OAAI
Bridging gaps in clinical trial accessibility and reimbursement for large B-cell lymphoma therapies across Europe

弥合欧洲大B细胞淋巴瘤疗法在临床试验可及性和报销方面的差距

2025-09-230
OAAI
Can we obtain prognostic information from healthy tissue uptake and volume in baseline 18F-FDG PET/CT imaging in diffuse large B-cell lymphoma?

我们能否从弥漫大B细胞淋巴瘤的基线18F-FDG PET/CT成像中获取健康组织摄取和体积的预后信息?

2025-08-180
OA
Measuring Total Metabolic Tumor Volume from 18F-FDG PET: A Reality Check

通过18F-FDG PET测量总代谢肿瘤体积:一次现实核查

2025-03-130
PRE
The Diagnostic Accuracy of 18F-FDG PET and 18F-FES PET for Staging Grade 1-2 Estrogen Receptor-Positive Breast Cancer

18F-FDG PET和18F-FES PET在分期G1-2雌激素受体阳性乳腺癌中的诊断准确性

RADIOLOGY
IF15.2
2025-03-010
PRE
Impact of bimekizumab and certolizumab pegol on efficacy, safety and osteoblastic activity in radiographic axial spondyloarthritis: results from a phase IIa, multicentre, randomised, double-blind, exploratory study with PET-CT imaging
2024-11-281
OAAI
Validation of an Artificial Intelligence-Based Prediction Model Using 5 External PET/CT Datasets of Diffuse Large B-Cell Lymphoma

基于人工智能的预测模型验证:使用5个外部PET/CT数据集的弥漫性大B细胞淋巴瘤

2024-10-033
PRE
Whole-Body HER2 Heterogeneity Identified on HER2 PET in HER2-Negative,-Low, and-Positive Metastatic Breast Cancer

在HER2-Negative,低和阳性转移性乳腺癌中通过HER2 PET鉴定的全身HER2异质性

2024-09-052
PRE